help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2005-2108
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
91/6/2126    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Owen, P. J. D.
Right arrow Articles by Lazarus, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Owen, P. J. D.
Right arrow Articles by Lazarus, J. H.
Related Collections
Right arrow Cardiovascular Endocrinology
Right arrow Thyroid
The Journal of Clinical Endocrinology & Metabolism Vol. 91, No. 6 2126-2132
Copyright © 2006 by The Endocrine Society

Subclinical Hypothyroidism, Arterial Stiffness, and Myocardial Reserve

P. J. D. Owen, C. Rajiv, D. Vinereanu, T. Mathew, A. G. Fraser and J. H. Lazarus

Centre for Endocrine and Diabetes Sciences (P.J.D.O., J.H.L.) and Department of Cardiology (C.R., D.V., T.M., A.G.F.), School of Medicine, Cardiff University, Cardiff CF14 4XN, Wales, United Kingdom

Address all correspondence and requests for reprints to: Professor J. H. Lazarus, Centre for Endocrine and Diabetes Sciences, Cardiff University, University Hospital of Wales, Cardiff CF14 4XN, Wales, United Kingdom. E-mail: lazarus{at}cf.ac.uk.

Context: Subclinical hypothyroidism (SCH) is associated with increased risk of cardiac disease; its impact on arterial function is less clear.

Objective: The objective of the study was the assessment of arterial and cardiac function.

Design: The study was a 6-month controlled observational study using pulse wave analysis and tissue Doppler dobutamine stress echocardiography.

Setting: The study was conducted at a thyroid clinic.

Patients: Nineteen female SCH patients with raised TSH, normal free T4, and no cardiovascular disease [aged 49.2 ± 3.8 yr; body mass index (BMI) 29.9 ± 6.7 kg/m2] were recruited from the thyroid clinic, and 10 female controls (aged 50.2 ± 3.4 yr; BMI 29.7 ± 7.2 kg/m2) also participated in the study.

Interventions: Incremental doses of L-thyroxine were used.

Main Outcome Measures: Indices of vascular stiffness and left ventricular echocardiographic function were measured.

Results: Baseline augmentation gradient was elevated in SCH, compared with controls [10.3 ± 5.1 (SD) mm Hg vs. 8.0 ± 4.2, P < 0.05]; when euthyroid (mean T4 dose 114 µg/d), it fell to 8.8 ± 5.3 mm Hg (P < 0.05). Heart rate-corrected augmentation index was 26.7 ± 9.9 vs. 18.8 ± 9.9% (P < 0.02), falling to 19.7 ± 9.6% (P < 0.001) after treatment. Time of travel of the reflected wave was 139.3 ± 11.7 msec, compared with 141.5 ± 8.8 msec in controls (P < 0.05), increasing to 144.9 ± 11.9 msec (P < 0.05). There were no differences in resting global, regional left ventricular function, or regional myocardial velocities during maximal dobutamine stress between SCH patients and controls, or in treated patients, compared with baseline.

Conclusions: Arterial stiffness was increased in SCH and improved with L-thyroxine, which may be beneficial, whereas myocardial functional reserve was similar to controls and remained unaltered after treatment.




This article has been cited by other articles:


Home page
Arch Intern MedHome page
B. O. Asvold, T. Bjoro, T. I. L. Nilsen, D. Gunnell, and L. J. Vatten
Thyrotropin Levels and Risk of Fatal Coronary Heart Disease: The HUNT Study
Arch Intern Med, April 28, 2008; 168(8): 855 - 860.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. R. Cappola
Subclinical Thyroid Dysfunction and the Heart
J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3404 - 3405.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Iqbal, H. Schirmer, P. Lunde, Y. Figenschau, K. Rasmussen, and R. Jorde
Thyroid Stimulating Hormone and Left Ventricular Function
J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3504 - 3510.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. O. Asvold, T. Bjoro, T. I. L. Nilsen, and L. J. Vatten
Association between Blood Pressure and Serum Thyroid-Stimulating Hormone Concentration within the Reference Range: A Population-Based Study
J. Clin. Endocrinol. Metab., March 1, 2007; 92(3): 841 - 845.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society